15/01/2019
Archivel participates in the STriTuVaD consortium
Archivel Farma is one of the eight partners of STriTuVad consortium, whose overall goal is…
Read More
Our facilities are engineered to manufacture small-customized clinical batches under GMPs.
RUTI® vaccine, our own project for fighting against Tuberculosis.
Mission & Values
Our mission is to guide you and your product from early stages of development to the first clinical phases.
Innovation
We are committed to new approaches, capable of providing real solutions to develop of innovative drug products.
Flexibility
Archivel Farma is an organization that learns from experience and constantly adapts to a changing and challenging environment.
Quality
A team with the highest professional standards guarantees the quality of our services and the rigor of the results.
Facilities
Our facilities are carefully engineered and uniquely built to support and enable early phase development for injectables and freeze dried products.
Commitment
We are committed to take your product forwards to early clinical stages, providing agile and flexible and customized services.
Leadership team
Ever-growing team of highly qualified pharmacy, biology and biopharmaceutical experts to find smart solutions to the challenging area of innovate drug development.
Team
Mercè Amat
Head of Research & Development
Leader of RUTI project
BIO
Mercè Amat has a PhD in Biochemistry from the University of Barcelona. She has broad professional experience in the sectors of bioscience and pharmaceuticals. For more than nine years, she led biological projects in respiratory and arthritis areas in the Research Departments at Almirall and at Menarini before joining Archivel Farma as Head of R&D in 2008. Currently, the focus of her work is on the development of RUTI®, most notably in the improvement of the manufacturing process and the product characterization. She is also conducting research on the use of RUTI® beyond tuberculosis.
Joan Casanovas
Head of the Production
Leader of Services
BIO
Joan Casanovas holds a Bachelor’s degree in Biology by the University of Barcelona. In recent years he has developed his professional career in London, working in the Cellular Therapy department at Great Ormond Street Hospital and Gene Therapy at University College London (UCL). He was involved in the translation of Lymphocyte manufacture for immunotherapy clinical trials, from research to GMP standards. Joan joined Archivel’s team in October 2019 as Production Manager, with the goal of manufacturing RUTI® vaccine.
Janina Duch
Quality Control Manager
BIO
Janina Duch is a Technician in Analysis and Quality Control from the IES Narcís Monturiol in Barcelona. With a professional trajectory of more than 10 years of experience working in the pharmaceutical industry, and numerous specific training courses around Quality, she has worked in companies as Sandoz and Biofarm Biotechnology.
Marc Jordan
Technical Director and Quality Assurance Manager
BIO
Marc is a graduate in Pharmacy by the University of Barcelona and has a Master’s degree in pharmaceutical industry (CESIF). He started his professional career in Fleming S.A, dedicated to Medical Devices. Afterwards, he incorporated into the Audit and Quality Systems Department at Grifols S.A.; where he was able to work with Biological Medicines. In 2017, he joined Archivel Farma S.L. as a Quality Assurance Technician and, at this moment, occupies the charge of Head of Quality Assurance and Qualified Person.
Funding
Private Funding
Archivel Farma is a private company, founded in 2005, which has as main investors TGT Group and Archivel Technologies, and has a minority participation of Laboratorios Reig Jofré.
In its different stages of development, the company has received financial support from investment funds such as FonsInnocat (BcnHighGrowth); Agora Invest; Inversions Valor Afegit; and Etios Capital Invest. All of them exited Archivel Farma in 2011.
Public Funding
The company has also received public funds from CDTI (Center for the Development of Industrial Technology); ENISA (Empresa Nacional de Innovación, SA); the missing Genoma España Foundation, now FECYT; and ACCIÓ, Catalan Agency for Business Competitiveness, as well as European funds through H2020 Research and Innovation projects.
Partnership
Archivel Farma co-develop Advanced therapy medicinal products (ATMPs) in a partnership with Reig Jofre Lab
Archivel Farma collaborates with COMSER Pharma in the development of freeze dried biological products as the manufacturer of clinical batches.
Archivel on the media
TV3, QuèQuiCom –2016
TV3, Trenta Minuts –2011
News
23/03/2018
Archivel Farma launches its new website on the World TB Day 2018
Archivel Farma has decide to launch its new website to coincide with the World TB…
Read More
20/03/2018
Archivel Farma and Laboratorios Silanes to collaborate in the development of the anti-tuberculosis vaccine RUTI® in México
RUTI® is the most promising therapeutic vaccine among the dozen projects that are currently being…
Read More
02/02/2018
Archivel Farma participated in the TBVI Symposium on therapeutic vaccination
Dr Pere-Joan Cardona, inventor of RUTI® vaccine and Scientific Advisor of Archivel Farma, and Olga…
Read More
19/10/2017
The RUTI® vaccine for the treatment of tuberculosis, presented to the WHO experts
Archivel Farma, owner of the vaccine, has started a Phase IIa clinical trial to assess…
Read More
20/03/2017
Archivel supports the 2017 World TB Day event in Barcelona
Archivel Farma is supporting a year more the activities organized in Barcelona around the World…
Read More
22/12/2016
TGT Group extends its participation in the capital of Archivel Farma
TGT Group, a strategic partner of Archivel Farma since January 2012, has increased its participation…
Read More
30/09/2016
Dr. Pere-Joan Cardona writes on TB therapeutic vaccines in ‘Frontiers in Microbiology’
The peer-reviewed journal Frontiers in Microbiology has just published an article by Dr. Pere-Joan Cardona, scientific advisor of…
Read More
28/03/2014
Archivel Farma looks for partners to start the last stage of development of RUTI® vaccine
Archivel has carried out a restructuring of its equipment to facilitate the entry of new…
Read More
28/02/2014
Results of RUTI®‘s Phase II clinical trial, published in Plos One
The prestigious magazine Plos One has just published the article "Safety, Tolerability, and Immunogenicity of…
Read More